Cargando…
Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer, with increasing prevalence worldwide. The mortality rate of HCC is similar to its incidence rate, which reflects its poor prognosis. At present, the diagnosis of HCC is still mostly dependent on invasive biopsy, imag...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903488/ https://www.ncbi.nlm.nih.gov/pubmed/29692630 http://dx.doi.org/10.2147/CMAR.S156837 |